Drug Developed at BYU Killing AIDS Virus

Drug Developed at BYU Killing AIDS Virus


Save Story
Leer en espaƱol

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

(KSL News) -- A new compound developed by Brigham Young University researchers is killing the AIDS virus.

The experimental drug is a derivative of similar compounds chemist Paul Savage began developing more than two years ago in this lab at BYU.

Savage and his colleagues synthesized this latest recipe for Vanderbilt University's School of Medicine. In experiments there, CSA-54, as it's called, didn't just slow down HIV - it killed the virus.

We first reported on Savage's work in 2004.

Similar results were shown with an antibiotic compound that killed drug resistant bacteria by uniquely mimicking the body's own natural defense system.

Both universities emphasize these lastest HIV/AIDS experiments are still only in the test tubes.

The compound has not been tested on animals, let alone humans.

Most recent Utah stories

Related topics

Utah
KSL.com Beyond Series

KSL Weather Forecast

KSL Weather Forecast
Play button